Designing a polyvalent inhibitor of anthrax toxin
暂无分享,去创建一个
George M. Whitesides | Ravi S. Kane | G. Whitesides | R. Kane | S. Metallo | R. Collier | B. Sellman | J. Mogridge | Pascal Deschatelets | M. Mourez | R. John Collier | Jeremy Mogridge | Bret R. Sellman | Pascal Deschatelets | Michael Mourez | Steve Metallo
[1] R. Kramer,et al. Spanning binding sites on allosteric proteins with polymer-linked ligand dimers , 1998, Nature.
[2] G M Whitesides,et al. Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into mechanism of inhibition. , 1995, Journal of medicinal chemistry.
[3] C. Pace,et al. How to measure and predict the molar absorption coefficient of a protein , 1995, Protein science : a publication of the Protein Society.
[4] R. Read,et al. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands , 2000, Nature.
[5] Timo Sorsa,et al. Tumor targeting with a selective gelatinase inhibitor , 1999, Nature Biotechnology.
[6] R. Collier,et al. Effect of Anthrax Toxin's Lethal Factor on Ion Channels Formed by the Protective Antigen (*) , 1995, The Journal of Biological Chemistry.
[7] R. Collier,et al. Protective antigen‐binding domain of anthrax lethal factor mediates translocation of a heterologous protein fused to its amino‐ or carboxy‐terminus , 1995, Molecular microbiology.
[8] S. Leppla,et al. Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides. , 1993, The Journal of biological chemistry.
[9] G. V. Vande Woude,et al. Anthrax toxins , 1999, Cellular and Molecular Life Sciences CMLS.
[10] R. Liddington,et al. Crystal structure of the anthrax toxin protective antigen , 1997, Nature.
[11] R. Collier,et al. Identification of residues lining the anthrax protective antigen channel. , 1998, Biochemistry.
[12] G. Whitesides,et al. Polyacrylamides bearing pendant .alpha.-sialoside groups strongly inhibit agglutination of erythrocytes by influenza virus , 1991 .
[13] George M Whitesides,et al. Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. , 1998, Angewandte Chemie.
[14] K D Paull,et al. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. , 1998, Science.
[15] Ronald W. Barrett,et al. Small Peptides as Potent Mimetics of the Protein Hormone Erythropoietin , 1996, Science.
[16] R. Collier,et al. Anthrax protective antigen: prepore-to-pore conversion. , 1999, Biochemistry.
[17] G M Whitesides,et al. A trivalent system from vancomycin.D-ala-D-Ala with higher affinity than avidin.biotin. , 1998, Science.
[18] N. Bovin,et al. Synthetic polymeric sialoside inhibitors of influenza virus receptor‐binding activity , 1990, FEBS letters.
[19] M. Zwick,et al. Phage-displayed peptide libraries. , 1998, Current opinion in biotechnology.
[20] R Lamb,et al. Anthrax. , 1973, Red Book (2018).
[21] G. Whitesides,et al. Polyacrylamides Bearing Pendant α-Sialoside Groups Strongly Inhibit Agglutination of Erythrocytes by Influenza Virus: The Strong Inhibition Reflects Enhanced Binding through Cooperative Polyvalent Interactions , 1996 .
[22] J S Wall,et al. Anthrax protective antigen forms oligomers during intoxication of mammalian cells. , 1994, The Journal of biological chemistry.
[23] R. Collier,et al. Characterization of membrane translocation by anthrax protective antigen. , 1998, Biochemistry.
[24] L. Kiessling,et al. Synthetic ligands point to cell surface strategies , 1998, Nature.
[25] J. Ezzell,et al. Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin , 1984, Infection and immunity.